84. サルコイドーシス [臨床試験数:143,薬物数:221(DrugBank:79),標的遺伝子数:82,標的パスウェイ数:165

Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03704610March 28, 201910/10/2018Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES STUDY)Extrathoracic SarcoidosisDrug: Infliximab;Drug: PlaceboAssistance Publique - Hôpitaux de ParisNULLRecruiting18 YearsN/AAll30Phase 3France
2EUCTR2014-002224-26-NL07/05/201503/02/2015Infliximab dosing based on blood concentrations in patients with sarcoidosis: smart dosingA new dosing strategy of infliximab versus standard dosing in patients with severe sarcoidosis: optimization of treatment - Concentration guided dosing of infliximab in sarcoidosis Sarcoidosis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]Trade Name: Remicade
Product Name: Remicade
St. Antonius HospitalNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands
3EUCTR2011-003630-13-NL22/11/201107/11/2011Tracer for the imaging of disease activity in sarcoidosis in the lung99mTc labelled anti-TNF-alpha for the imaging of disease activity in pulmonary sarcoidosis - TISS Pulmonary sarcoidosis
MedDRA version: 17.0Level: PTClassification code 10037430Term: Pulmonary sarcoidosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Product Name: 99mTc-Infliximab
Product Code: not applicable
INN or Proposed INN: not applicable
Other descriptive name: 99m technetium infliximab
Sint Antonius HospitalNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands
4NCT00073437October 200320/11/2003A Study of Infliximab in Patients With SarcoidosisA Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy of Infliximab (Remicade?) in Subjects With Chronic Sarcoidosis With Pulmonary Involvement.SarcoidosisDrug: InfliximabCentocor, Inc.NULLCompleted18 YearsN/ABoth139Phase 3United States;Austria;Belgium;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;Italy